Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes

Abstract

Women with persistent aPL on aspirin had pregnancy outcomes that were similar to controls. These data suggest that in the absence of other risk factors, women with aPL do not need intense antenatal surveillance or modified management in pregnancy.